• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Angioedema without urticaria after recent initiation of celecoxib.近期使用塞来昔布后出现无荨麻疹性血管性水肿。
BMJ Case Rep. 2023 Sep 22;16(9):e255446. doi: 10.1136/bcr-2023-255446.
2
Safety of etoricoxib, a new cyclooxygenase 2 inhibitor, in patients with nonsteroidal anti-inflammatory drug-induced urticaria and angioedema.新型环氧化酶-2抑制剂依托考昔在非甾体抗炎药诱发的荨麻疹和血管性水肿患者中的安全性。
Ann Allergy Asthma Immunol. 2005 Aug;95(2):154-8. doi: 10.1016/S1081-1206(10)61205-7.
3
NSAID-induced urticaria and angioedema: a reappraisal of its clinical management.非甾体抗炎药诱发的荨麻疹和血管性水肿:对其临床管理的重新评估
Am J Clin Dermatol. 2002;3(9):599-607. doi: 10.2165/00128071-200203090-00002.
4
Safety of selective cyclooxygenase-2 inhibitors and a basic non-steroidal anti-inflammatory drug (NSAID) in Japanese patients with NSAID-induced urticaria and/or angioedema: Comparison of meloxicam, etodolac and tiaramide.选择性环氧化酶-2抑制剂和一种基础非甾体抗炎药(NSAID)在日本非甾体抗炎药诱发的荨麻疹和/或血管性水肿患者中的安全性:美洛昔康、依托度酸和替拉米特的比较
J Dermatol. 2007 Mar;34(3):172-7. doi: 10.1111/j.1346-8138.2007.00244.x.
5
Provocation tests with the offending nonsteroidal anti-inflammatory drugs in patients with urticaria/angioedema reactions.在荨麻疹/血管性水肿反应患者中进行致过敏的非甾体抗炎药激发试验。
Allergy Asthma Proc. 2012 Sep-Oct;33(5):421-6. doi: 10.2500/aap.2012.33.3590.
6
Oral drug challenges in non-steroidal anti-inflammatory drug-induced urticaria, angioedema and anaphylaxis.非甾体类抗炎药诱导的荨麻疹、血管性水肿和过敏反应的口服药物挑战。
Intern Med J. 2012 Jun;42(6):665-71. doi: 10.1111/j.1445-5994.2011.02601.x.
7
Clinical management of patients with a history of urticaria/angioedema induced by multiple NSAIDs: an expert panel review.多类非甾体抗炎药诱导的荨麻疹/血管性水肿患者的临床管理:专家小组综述。
Int Arch Allergy Immunol. 2013;160(2):126-33. doi: 10.1159/000342424. Epub 2012 Sep 25.
8
Natural evolution in patients with nonsteroidal anti-inflammatory drug-induced urticaria/angioedema.非甾体抗炎药诱导的荨麻疹/血管性水肿患者的自然演变。
Allergy. 2017 Sep;72(9):1346-1355. doi: 10.1111/all.13147. Epub 2017 Mar 20.
9
Response to a selective COX-2 inhibitor in patients with urticaria/angioedema induced by nonsteroidal anti-inflammatory drugs.对非甾体抗炎药引起的荨麻疹/血管性水肿患者使用选择性 COX-2 抑制剂的反应。
Allergy. 2011 Nov;66(11):1428-33. doi: 10.1111/j.1398-9995.2011.02684.x. Epub 2011 Aug 11.
10
Value of the clinical history in the diagnosis of urticaria/angioedema induced by NSAIDs with cross-intolerance.临床病史在诊断 NSAIDs 交叉不耐受所致荨麻疹/血管性水肿中的价值。
Clin Exp Allergy. 2013 Jan;43(1):85-91. doi: 10.1111/cea.12013.

本文引用的文献

1
Evaluation and Management of Angioedema in the Emergency Department.急诊科血管性水肿的评估与管理。
West J Emerg Med. 2019 Jul;20(4):587-600. doi: 10.5811/westjem.2019.5.42650. Epub 2019 Jul 2.
2
NSAID hypersensitivity - recommendations for diagnostic work up and patient management.非甾体抗炎药超敏反应——诊断检查及患者管理建议
Allergo J Int. 2018;27(4):114-121. doi: 10.1007/s40629-018-0064-0. Epub 2018 May 25.
3
NSAIDs hypersensitivity: questions not resolved.非甾体抗炎药超敏反应:未解决的问题。
Curr Opin Allergy Clin Immunol. 2018 Aug;18(4):291-301. doi: 10.1097/ACI.0000000000000454.
4
Epidemiology of ACE Inhibitor Angioedema Utilizing a Large Electronic Health Record.利用大型电子健康记录研究血管紧张素转换酶抑制剂所致血管性水肿的流行病学
J Allergy Clin Immunol Pract. 2017 May-Jun;5(3):744-749. doi: 10.1016/j.jaip.2017.02.018. Epub 2017 Apr 1.
5
Angioedema: Classification, management and emerging therapies for the perioperative physician.血管性水肿:围手术期医生的分类、管理及新兴治疗方法
Indian J Anaesth. 2016 Aug;60(8):534-41. doi: 10.4103/0019-5049.187776.
6
Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs.非甾体抗炎药过敏的分类及诊断与管理的实用方法。
Allergy. 2013 Oct;68(10):1219-32. doi: 10.1111/all.12260. Epub 2013 Oct 5.
7
Angioedema.血管性水肿。
World Allergy Organ J. 2008 Jun;1(6):103-13. doi: 10.1097/WOX.0b013e31817aecbe.
8
Recent advances in drug-induced angioedema.药物诱导性血管性水肿的最新进展。
Allergol Int. 2012 Dec;61(4):545-57. doi: 10.2332/allergolint.12-RAI-0493.
9
Angioedema after nonsteroidal antiinflammatory drug initiation in a patient stable on an angiotensin-converting-enzyme inhibitor.在血管紧张素转换酶抑制剂稳定治疗的患者中,使用非甾体抗炎药后发生血管性水肿。
Am J Health Syst Pharm. 2010 Aug 15;67(16):1351-3. doi: 10.2146/ajhp090348.
10
Anaphylaxis.过敏反应。
J Allergy Clin Immunol. 2010 Feb;125(2 Suppl 2):S161-81. doi: 10.1016/j.jaci.2009.12.981.

近期使用塞来昔布后出现无荨麻疹性血管性水肿。

Angioedema without urticaria after recent initiation of celecoxib.

机构信息

Internal Medicine, OhioHealth Riverside Methodist Hospital, Columbus, Ohio, USA.

Internal Medicine, OhioHealth Riverside Methodist Hospital, Columbus, Ohio, USA

出版信息

BMJ Case Rep. 2023 Sep 22;16(9):e255446. doi: 10.1136/bcr-2023-255446.

DOI:10.1136/bcr-2023-255446
PMID:37739445
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10533717/
Abstract

Angioedema is potentially life-threating swelling of integument and mucosa that has multiple potential aetiologies with varying mechanisms. Drug-induced angioedema is often easily correlated with the offending agent and can be prevented with discontinuation of the medication. Many medications have now been implicated in drug-induced angioedema but the two most common are ACE inhibitors and non-steroidal anti-inflammatory drugs (NSAIDs). This case highlights severe angioedema secondary to celecoxib and reviews varying aetiologies of angioedema and NSAID hypersensitivity reactions.

摘要

血管性水肿是一种潜在危及生命的皮肤和黏膜肿胀,其具有多种潜在病因和不同的发病机制。药物诱导的血管性水肿通常与致病药物容易相关,并且可以通过停止使用药物来预防。许多药物已被牵连到药物诱导的血管性水肿中,但最常见的两种是血管紧张素转换酶抑制剂(ACE 抑制剂)和非甾体抗炎药(NSAIDs)。本病例强调了塞来昔布引起的严重血管性水肿,并回顾了血管性水肿和 NSAID 过敏反应的不同病因。